Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

BENZODIAZEPINE - ANVISA Registration 80258020049

Access comprehensive regulatory information for BENZODIAZEPINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80258020049 and manufactured by GUANGZHOU WONDFO BIOTECH CO., LTD.. The registration is held by CEPALAB LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including MICROGENICS CORPORATION, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80258020049
Registration Details
ANVISA Registration Number: 80258020049
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

FAST TEST BZO
Risk Class II

Registration Details

80258020049

25351553954201718

02248312000144

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Feb 14, 2018

VIGENTE

09/18/2025 19:00:01